TERT and metastatic malignant neoplasm in the lymph nodes: The results of the subgroup analyses also indicated that TERT promoter mutations were not significantly associated with some high-risk tumor features (e.g., extrathyroidal extension and lymph node metastasis) of PTC in patients from Asia.